Navigation Links
Consensus on "Combination Therapy" for Breast Cancer ,,

Breast cancer is the commonest cancer among women in the world. There has been some on going controversy on certain aspects of treatment modalities of this cancer. Besides surgery there are other options to treat the cancer including radiation, chemotherapy and hormonal therapy. Now at a three-day conference at the National Institutes of Health doctors have agreed to a consensus on the combination therapy for the cancer. Dctors have agreed that the combination therapy for women with breast cancer is beneficial. Depending on a woman's stage of the disease the experts recommend surgery along with either chemotherapy or hormonal therapy.

To help in the decision-making, experts came up with their own recommendations as follows:

1. Women whose breast tumors contain estrogen receptors, regardless of other factors, are recommended to use hormonal therapy. The panel suggests five years of drug-Tamoxifen as the standard hormonal adjuvant therapy. Hormonal therapy is not suggested for women whose tumors do not have hormone receptors.

2. Women who have had a mastectomy and have four or more cancerous lymph nodes can best benefit from post-surgical radiation. At this point the panel says there is not enough evidence that women with three or fewer cancerous lymph nodes benefit from radiation.

Patricia Eifel of Anderson Cancer Center in Houston, said to one of the medical news agencies that, "Women with breast cancer have more treatment options and a better chance of surviving their disease than ever before. At the same time, making treatment decisions has become a more complex process for them and their physicians due to a growing list of effective options."

Page: 1

Related medicine news :

1. Climate Talks Reach Consensus in Bangkok
2. Women Alerted against "Natural Hormone Replacement Therapy"
3. Breast cancer treatment to be determined by gene test
4. Breast Feeding prevents obesity later on in life
5. Breast milk is essential
6. Breast Cancer Surgery Causes Psychological problems
7. Breast cancer evidence
8. Letrozole Beats Tamoxifen in Breast Cancer Therapy
9. Breast screening among diabetic women
10. Breast feeding can alter hormones
11. Diet, Sunlight connected to Breast Cancer Risk
Post Your Comments:

(Date:11/30/2015)... ... December 01, 2015 , ... ... Colon as a 2015-2016 inductee into its VIP Woman of the Year ... is the nation’s leading networking organization exclusively for professional women, boasting 850,000 members ...
(Date:11/30/2015)... ... December 01, 2015 , ... The National ... 2015-2016 inductee into its VIP Woman of the Year Circle. She is recognized ... networking organization exclusively for professional women, boasting 850,000 members and over 200 operating ...
(Date:11/30/2015)... ... December 01, 2015 , ... Live Very Well is ... insurance plans on . The multi-carrier insurance exchange platform offers individual ... allowing consumers to compare, quote and match plans to meet their needs. ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... Until now, ... criteria set forth in the MOMS (Management of Myelomeningocele Study) trial. One of these ... Control and Prevention), a BMI of 18.5 to 24.9 is considered normal, 25 - ...
(Date:11/30/2015)... ... 2015 , ... Stress, anxiety, illness, infection or even a need for eyeglasses ... Heather Spader, MD, a new pediatric neurosurgeon at Joe DiMaggio Children’s Hospital in Hollywood, ... tumors. , “Bad headaches that don’t go away, that don’t have any ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015   Royal Philips ... ScanWise Implant, the industry,s first MRI guided user interface ... scanning of patients with MR Conditional implants, such as ... the 2015 Radiological Society of North America Annual ... exams and supports diagnostic confidence of this growing patient ...
(Date:11/30/2015)... Nov. 30, 2015 Baxalta Incorporated ... leader dedicated to delivering transformative therapies to ... conditions, today announced the launch and first ... an extended circulating half-life recombinant factor VIII ... full-length ADVATE [Antihemophilic Factor (Recombinant)]. The treatment ...
(Date:11/30/2015)... PUNE, India , November 30, 2015 ... new market research report "Dental Lasers Market by Product (Soft ... Treatment, Periodontitis), End User (Hospitals, Clinics), and Geography - Global ... USD 224.7 Million by 2020, at a CAGR of 5.2% ... , Browse 140 market data Tables and 62 Figures spread ...
Breaking Medicine Technology: